Ixazomib Maintenance in Patients With Newly Diagnosed Mantle Cell Lymphoma(MCL)

Clinical trial NCT03616782 · UNKNOWN

Trial details

NCT number: NCT03616782
Sponsor: Ho Sup Lee
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Mantle Cell Lymphoma

Start date: 2018-12-24
Primary completion: 2026-05-31
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.